Cargando…

Serum and Prostatic Tissue Concentrations of Cefazolin, Ciprofloxacin and Fosfomycin after Prophylactic Use for Transurethral Resection of the Prostate

The optimal drug of choice, its time of administration and duration of antibiotic prophylaxis in patient undergoing a TURP procedure are still matters of debate. In this study, we evaluated the concentrations of cefazolin, ciprofloxacin and fosfomycin in the human prostate in a cohort of men undergo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sobels, Annemieke, Lentjes, Koen J., Froeling, Frank M. J. A., van Nieuwkoop, Cees, Wilms, Erik B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855043/
https://www.ncbi.nlm.nih.gov/pubmed/36671223
http://dx.doi.org/10.3390/antibiotics12010022
_version_ 1784873280779321344
author Sobels, Annemieke
Lentjes, Koen J.
Froeling, Frank M. J. A.
van Nieuwkoop, Cees
Wilms, Erik B.
author_facet Sobels, Annemieke
Lentjes, Koen J.
Froeling, Frank M. J. A.
van Nieuwkoop, Cees
Wilms, Erik B.
author_sort Sobels, Annemieke
collection PubMed
description The optimal drug of choice, its time of administration and duration of antibiotic prophylaxis in patient undergoing a TURP procedure are still matters of debate. In this study, we evaluated the concentrations of cefazolin, ciprofloxacin and fosfomycin in the human prostate in a cohort of men undergoing TURP. We compared prostate tissue concentrations to the serum concentrations and MICs of common uropathogens, to determine the appropriateness of the current presurgical prophylactic antibiotics and to gain supportive data about the suitability of fosfomycin for antibiotic prophylaxis in men undergoing urological procedures of the prostate. After a single intravenous dose of cefazoline or an oral dose of ciprofloxacin prior to TURP, concentrations in serum and prostate tissue of well above the MIC (EUCAST breakpoint) of common uropathogens (Enterobacterales) were reached, and both antibiotics seem potentially effective in preventing postsurgical infections. A single dose of oral and intravenous administration of fosfomycin both led to serum concentrations above the MIC for uncomplicated urinary tract infections (8 µg/mL). The MIC for other infections (32 µg/mL) was only reached after a single dose of intravenous fosfomycin. We were unable to detect fosfomycin concentrations in prostate tissue.
format Online
Article
Text
id pubmed-9855043
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98550432023-01-21 Serum and Prostatic Tissue Concentrations of Cefazolin, Ciprofloxacin and Fosfomycin after Prophylactic Use for Transurethral Resection of the Prostate Sobels, Annemieke Lentjes, Koen J. Froeling, Frank M. J. A. van Nieuwkoop, Cees Wilms, Erik B. Antibiotics (Basel) Article The optimal drug of choice, its time of administration and duration of antibiotic prophylaxis in patient undergoing a TURP procedure are still matters of debate. In this study, we evaluated the concentrations of cefazolin, ciprofloxacin and fosfomycin in the human prostate in a cohort of men undergoing TURP. We compared prostate tissue concentrations to the serum concentrations and MICs of common uropathogens, to determine the appropriateness of the current presurgical prophylactic antibiotics and to gain supportive data about the suitability of fosfomycin for antibiotic prophylaxis in men undergoing urological procedures of the prostate. After a single intravenous dose of cefazoline or an oral dose of ciprofloxacin prior to TURP, concentrations in serum and prostate tissue of well above the MIC (EUCAST breakpoint) of common uropathogens (Enterobacterales) were reached, and both antibiotics seem potentially effective in preventing postsurgical infections. A single dose of oral and intravenous administration of fosfomycin both led to serum concentrations above the MIC for uncomplicated urinary tract infections (8 µg/mL). The MIC for other infections (32 µg/mL) was only reached after a single dose of intravenous fosfomycin. We were unable to detect fosfomycin concentrations in prostate tissue. MDPI 2022-12-23 /pmc/articles/PMC9855043/ /pubmed/36671223 http://dx.doi.org/10.3390/antibiotics12010022 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sobels, Annemieke
Lentjes, Koen J.
Froeling, Frank M. J. A.
van Nieuwkoop, Cees
Wilms, Erik B.
Serum and Prostatic Tissue Concentrations of Cefazolin, Ciprofloxacin and Fosfomycin after Prophylactic Use for Transurethral Resection of the Prostate
title Serum and Prostatic Tissue Concentrations of Cefazolin, Ciprofloxacin and Fosfomycin after Prophylactic Use for Transurethral Resection of the Prostate
title_full Serum and Prostatic Tissue Concentrations of Cefazolin, Ciprofloxacin and Fosfomycin after Prophylactic Use for Transurethral Resection of the Prostate
title_fullStr Serum and Prostatic Tissue Concentrations of Cefazolin, Ciprofloxacin and Fosfomycin after Prophylactic Use for Transurethral Resection of the Prostate
title_full_unstemmed Serum and Prostatic Tissue Concentrations of Cefazolin, Ciprofloxacin and Fosfomycin after Prophylactic Use for Transurethral Resection of the Prostate
title_short Serum and Prostatic Tissue Concentrations of Cefazolin, Ciprofloxacin and Fosfomycin after Prophylactic Use for Transurethral Resection of the Prostate
title_sort serum and prostatic tissue concentrations of cefazolin, ciprofloxacin and fosfomycin after prophylactic use for transurethral resection of the prostate
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855043/
https://www.ncbi.nlm.nih.gov/pubmed/36671223
http://dx.doi.org/10.3390/antibiotics12010022
work_keys_str_mv AT sobelsannemieke serumandprostatictissueconcentrationsofcefazolinciprofloxacinandfosfomycinafterprophylacticusefortransurethralresectionoftheprostate
AT lentjeskoenj serumandprostatictissueconcentrationsofcefazolinciprofloxacinandfosfomycinafterprophylacticusefortransurethralresectionoftheprostate
AT froelingfrankmja serumandprostatictissueconcentrationsofcefazolinciprofloxacinandfosfomycinafterprophylacticusefortransurethralresectionoftheprostate
AT vannieuwkoopcees serumandprostatictissueconcentrationsofcefazolinciprofloxacinandfosfomycinafterprophylacticusefortransurethralresectionoftheprostate
AT wilmserikb serumandprostatictissueconcentrationsofcefazolinciprofloxacinandfosfomycinafterprophylacticusefortransurethralresectionoftheprostate